ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 151 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 1.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $34,000 | +25.9% | 12,000 | +100.0% | 0.00% | 0.0% |
| Q3 2017 | $27,000 | -3.6% | 6,000 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $28,000 | -82.6% | 6,000 | -84.3% | 0.00% | -80.0% |
| Q1 2017 | $161,000 | -42.9% | 38,200 | -44.0% | 0.01% | -37.5% |
| Q4 2016 | $282,000 | -51.7% | 68,200 | -5.5% | 0.01% | -52.9% |
| Q3 2016 | $584,000 | +3.7% | 72,200 | 0.0% | 0.02% | +6.2% |
| Q2 2016 | $563,000 | -9.2% | 72,200 | -10.0% | 0.02% | -15.8% |
| Q1 2016 | $620,000 | -28.4% | 80,200 | 0.0% | 0.02% | -29.6% |
| Q4 2015 | $866,000 | +71.1% | 80,200 | +9.6% | 0.03% | +28.6% |
| Q3 2015 | $506,000 | -31.3% | 73,200 | -12.0% | 0.02% | -22.2% |
| Q2 2015 | $737,000 | +1149.2% | 83,200 | +1286.7% | 0.03% | +1250.0% |
| Q1 2015 | $59,000 | -19.2% | 6,000 | 0.0% | 0.00% | -33.3% |
| Q4 2014 | $73,000 | +21.7% | 6,000 | 0.0% | 0.00% | +50.0% |
| Q3 2014 | $60,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $56,305,000 | 7.98% |
| BVF INC/IL | 2,423,300 | $10,008,000 | 2.01% |
| EMORY UNIVERSITY | 454,102 | $1,875,000 | 1.85% |
| DAFNA Capital Management LLC | 196,500 | $812,000 | 0.71% |
| Orbimed Advisors | 13,107,200 | $54,133,000 | 0.69% |
| RTW INVESTMENTS, LP | 286,285 | $1,182,000 | 0.44% |
| Marcus Capital, LLC | 100,000 | $413,000 | 0.44% |
| Rock Springs Capital Management LP | 1,375,000 | $5,679,000 | 0.38% |
| Spark Investment Management LLC | 978,600 | $4,041,000 | 0.33% |
| Bellevue Group AG | 240,000 | $991,000 | 0.20% |